These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
515 related items for PubMed ID: 18330889
1. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations. Mahdavinia M, Bishehsari F, Verginelli F, Cumashi A, Lattanzio R, Sotoudeh M, Ansari R, Semeraro D, Hormazdi M, Fakheri H, Rakhshani N, De Lellis L, Curia MC, Cama A, Piantelli M, Malekzadeh R, Iacobelli S, Mariani-Costantini R. J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889 [Abstract] [Full Text] [Related]
2. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer. Catalano T, Curia MC, Aceto G, Verginelli F, Cascinu S, Cama A, Mariani-Costantini R, Teti D, Battista P. Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965 [Abstract] [Full Text] [Related]
9. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [Abstract] [Full Text] [Related]
10. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer? Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Amato A, Calò V, Dardanoni G, Morello V, La Farina M, Albanese I, Tomasino RM, Gebbia N, Russo A. J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467 [Abstract] [Full Text] [Related]
14. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients. Conzelmann M, Linnemann U, Berger MR. Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598 [Abstract] [Full Text] [Related]
15. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma. Isa T, Tomita S, Nakachi A, Miyazato H, Shimoji H, Kusano T, Muto Y, Furukawa M. Hepatogastroenterology; 2002 Jun; 49(45):604-8. PubMed ID: 12063950 [Abstract] [Full Text] [Related]
16. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation. Wang Y, Yamaguchi Y, Watanabe H, Ohtsubo K, Wakabayashi T, Sawabu N. J Gastroenterol; 2002 Jun; 37(10):831-9. PubMed ID: 12424567 [Abstract] [Full Text] [Related]
17. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. van Engeland M, Roemen GM, Brink M, Pachen MM, Weijenberg MP, de Bruïne AP, Arends JW, van den Brandt PA, de Goeij AF, Herman JG. Oncogene; 2002 May 23; 21(23):3792-5. PubMed ID: 12032847 [Abstract] [Full Text] [Related]
18. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. Chang SC, Lin JK, Lin TC, Liang WY. Int J Oncol; 2005 Jan 23; 26(1):65-75. PubMed ID: 15586226 [Abstract] [Full Text] [Related]
19. Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years. Alsop K, Mead L, Smith LD, Royce SG, Tesoriero AA, Young JP, Haydon A, Grubb G, Giles GG, Jenkins MA, Hopper JL, Southey MC. Eur J Cancer; 2006 Jul 23; 42(10):1357-61. PubMed ID: 16765042 [Abstract] [Full Text] [Related]